InspireMD (NSPR) Net Margin Growth (5y) (2015 - 2025)
InspireMD (NSPR) Net Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | -29,330.00 |
| Jun 30, 2025 | 6,011.00 |
| Mar 31, 2025 | -55,405.00 |
| Dec 31, 2024 | -271,542.00 |
| Sep 30, 2024 | -24,707.00 |
| Jun 30, 2024 | -31,206.00 |
| Mar 31, 2024 | 28,210.00 |
| Dec 31, 2023 | -68,683.00 |
| Sep 30, 2023 | -10,115.00 |
| Jun 30, 2023 | -21,923.00 |
| Mar 31, 2023 | -11,635.00 |
| Dec 31, 2022 | 18,470.00 |
| Sep 30, 2022 | -2,596.00 |
| Jun 30, 2022 | 5,563.00 |
| Mar 31, 2022 | 7,095.00 |
| Dec 31, 2021 | 41,072.00 |
| Sep 30, 2021 | 4,526.00 |
| Jun 30, 2021 | 2,251.00 |
| Mar 31, 2021 | 7,763.00 |